Related Experiment Video
Updated: Sep 29, 2026
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal
Minoru Fukuchi1, Norihiro Masuda, Tatsuya Miyazaki
1Department of Surgery, Gunma University Faculty of Medicine, Maebashi, Japan. mfukuchi@med.gunma-u.ac.jp
Background:
Transforming growth factor-beta (TGF-beta) has antiproliferative effects in various cells, and inactivation of the TGF-beta signaling pathway contributes to tumor progression or development. Smad4, a tumor suppressor gene, is a central mediator in the signaling pathways of the TGF-beta superfamily. This study was undertaken to clarify the correlation between Smad4 expression and the clinicopathologic characteristics of patients with esophageal squamous cell carcinoma (SCC). The authors also investigated the expression of components of the TGF-beta signaling pathway in seven established cell lines derived from esophageal SCC.
Methods:
Immunohistochemistry for Smad4 using monoclonal anti-Smad4 antibody was performed on surgical specimens obtained from 80 patients with esophageal SCC. In seven cell lines, the authors examined the expression of components of the TGF-beta signaling pathway using Western and Northern blot analyses.
Results:
There was a significant inverse correlation between Smad4 expression and both depth of invasion (P = 0.0008) and pathologic stage (P = 0.0079). The expression of Smad4 proteins could be detected in five of seven cell lines. The expression of TGF-beta type II receptor protein was decreased in two of seven cell lines, and the expression of both Smad2 and Smad3 proteins was decreased in only one cell line. The level of expression of Smad4 mRNA did not differ dramatically between cell lines and was not correlated with the quantity of Smad4 protein.
Conclusions:
In this study, the expression of Smad4 protein appeared to be correlated with the depth of invasion of esophageal SCC. The loss of Smad4 expression was not regulated at the level of transcription.
Insights
Smad4 protein expression inversely correlates with invasion depth in esophageal squamous cell carcinoma (SCC). Loss of Smad4 in SCC is not due to transcriptional regulation, suggesting post-transcriptional mechanisms are involved.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Transforming growth factor-beta (TGF-beta) signaling is crucial for cell growth, and its pathway inactivation promotes tumor development.
- Smad4, a key tumor suppressor gene, mediates TGF-beta superfamily signaling.
- Esophageal squamous cell carcinoma (SCC) progression is linked to alterations in these pathways.
Purpose of the Study:
- To determine the correlation between Smad4 expression and clinicopathologic features in esophageal SCC patients.
- To investigate the expression of TGF-beta signaling pathway components in esophageal SCC cell lines.
Main Methods:
- Immunohistochemistry was used to assess Smad4 protein expression in 80 esophageal SCC surgical specimens.
- Western and Northern blot analyses were performed on seven esophageal SCC cell lines to examine TGF-beta pathway component expression.
Main Results:
- A significant inverse correlation was observed between Smad4 expression and depth of invasion (P=0.0008) and pathologic stage (P=0.0079).
- Smad4 protein was detected in five of seven cell lines.
- TGF-beta type II receptor and Smad2/3 protein expression showed decreased levels in some cell lines, while Smad4 mRNA levels were consistent and not correlated with protein levels.
Conclusions:
- Smad4 protein expression is significantly correlated with the depth of invasion in esophageal SCC.
- The downregulation of Smad4 expression in esophageal SCC is not regulated at the transcriptional level.
Related Concept Videos
01:16TGF - β Signaling Pathway
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...